Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 803.60
+7.70 (0.97%)
Jun 19, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 17.88 billion as of June 18, 2026. Its market cap has increased by 160.19% in one year.
Market Cap
17.88B
Enterprise Value
18.58B
Revenue
2.52B
Ranking
n/a
PE Ratio
58.66
Stock Price
803.60
Market Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 17.88B, an increase of 3,092.25%. That is a compound annual growth rate of 48.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 17.88B | 96.38% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 59.70B |
| Innova Captab | 53.39B |
| Orchid Pharma | 51.14B |
| RPG Life Sciences | 37.68B |
| Solara Active Pharma Sciences | 27.34B |
| Indoco Remedies | 21.42B |
| Beta Drugs | 19.67B |
| Windlas Biotech | 16.86B |